BRCR Global vs a First-in-Human Device CRO (bioaccess®)

BRCR Global vs bioaccess®: what BRCR Global publishes, where it fits in Brazil, and when a medical-device first-in-human specialist in Latin America since 2010 is the better tool.

If you typed BRCR Global into a search box, you are probably building a CRO or site shortlist for Brazil. This article uses only what is public about BRCR Global (www.brcrglobal.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What BRCR Global publishes

BRCR Global is a clinical research organization headquartered in Weston, Florida, with research sites in Florida and a network across Latin America and the Caribbean, including Mexico, Brazil, Peru, Ecuador, Colombia and Costa Rica. Its site lists functional services such as recruitment, start-up, regulatory and legal representation, clinical operations and monitoring, safety, logistics and data operations, with an emphasis on oncology.

BRCR Global vs bioaccess®

Dimension BRCR Global bioaccess®
Core focus FSP and site network across the Americas, oncology emphasis First-in-human and early feasibility studies for medical devices
Geography See provider site Latin America, since 2010
Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
After the trial See provider site Live multi-country sanitary registration and in-country holder service

Where each one fits

If you need functional-service support or an oncology site network across the Americas, BRCR Global’s published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including BRCR Global, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Brazil. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the BRCR Global public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

← Back to Blog · Contact bioaccess®